Swissmedic has issued an announcement regarding the immediate recall of batch number 251347651 of NaCl B. Braun infusion solution. This recall affects products distributed to the retail level and is imperative for healthcare professionals, distributors, and regulatory teams to address promptly. The decision was made following quality concerns to ensure patient safety and compliance with regulatory standards.
What changed?
On October 31, 2025, Swissmedic released details regarding the recall of batch number 251347651 of NaCl B. Braun infusion solution. The agency confirmed that products from this batch would be withdrawn from the retail sector, marking a critical measure aimed at mitigating risks to patient safety.
Affected batch details
The recall specifically targets the NaCl B. Braun infusion solution with batch number 251347651. Healthcare facilities, pharmacies, and distributors are instructed to halt usage and distribution of the affected products immediately. Users should ensure proper disposal, adhering to medical waste guidelines.
Affected product
- Product: NaCl B. Braun infusion solution
- Batch number: 251347651
- Recall scope: Retail sector
Why compliance matters
Batch recalls are critical for protecting patient safety and ensuring adherence to regulatory standards. Medical device and pharmaceutical manufacturers are held accountable for delivering products that consistently meet quality specifications. This recall demonstrates Swissmedic’s commitment to addressing quality deficiencies promptly.
Implications for healthcare providers
Healthcare teams are advised to verify existing stock. Any products matching batch 251347651 must be removed from inventory to mitigate risks of adverse events potentially linked to compromised product quality. Accurate reporting of removed products to distributors is essential for traceability.
Frequently Asked Questions
-
Q1: What is the primary reason for the recall?
The recall was initiated due to concerns over the quality of the specific batch that could impact patient safety.
-
Q2: Who does this impact?
This impacts healthcare providers, pharmacies, and distributors that may have stock of the affected batch.
-
Q3: How can distributors manage this recall?
Distributors should follow official instructions from Swissmedic and cooperate in either returning or securely disposing of the affected batch.
Conclusion
Swissmedic’s proactive recall of NaCl B. Braun infusion solution highlights the importance of addressing quality deficiencies promptly to ensure patient safety. Healthcare providers, distributors, and related stakeholders should adhere to the outlined actions to achieve compliance and mitigate risks. For further guidance, refer to Swissmedic’s official announcement.
Disclaimer
This content is intended for healthcare professionals and does not constitute legal, regulatory, or professional advice. Always refer to official regulatory documentation for accurate details.
Swissmedic Information
For full information about the Swissmedic announcement, see the link below.
https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/market-surveillance/qualitaetsmaengel-und-chargenrueckrufe/batch-recalls/chargenrueckruf-nacl-b-braun-injlsg.html